Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial

Wiebe J, Byrne RA, Alfonso F, Maeng M, Bradaric C, Kretov E, Cuesta J, Kuna C, Ibrahim T, Rivero F, Heugl M, Christiansen EH, Joner M, Schunkert H, Laugwitz KL, Kastrati A, Cassese S (2022)

Publication Type: Journal article

Publication year: 2022

Journal

EuroIntervention Europa Group

Book Volume: 17

Pages Range: 1348-1351

Journal Issue: 16

DOI: 10.4244/EIJ-D-21-00653

Involved external institutions

Technische Universität München (TUM)

Germany (DE) E.Meshalkin National Medical Research Center of Ministry of Health of Russian Federation

Russian Federation (RU) Mater Private Hospital / Ospidéal Príobháideach an Mater

Ireland (IE) Hospital Universitario De La Princesa

Spain (ES) Aarhus University Hospital / Aarhus Universitetshospital

Denmark (DK) Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK e.V.)

Germany (DE)

How to cite

APA:

Wiebe, J., Byrne, R.A., Alfonso, F., Maeng, M., Bradaric, C., Kretov, E.,... Cassese, S. (2022). Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial. EuroIntervention, 17(16), 1348-1351. https://doi.org/10.4244/EIJ-D-21-00653

MLA:

Wiebe, Jens, et al. "Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial." EuroIntervention 17.16 (2022): 1348-1351.

BibTeX: Download